Skip to main content

Nevro Corp(NVRO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Nevro Names New Chief Commercial Officer

PR Newswire - Mon Jun 5, 2023

Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus

Company Updates Second Quarter 2023 Revenue Guidance

REDWOOD CITY, Calif., June 5, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Greg Siller has been appointed Senior Vice President and Chief Commercial Officer of Nevro, effective June 19, 2023.  Mr. Siller replaces Niamh Pellegrini, who will be leaving the organization effective June 9.  The company also announced that in conjunction with this appointment, it is updating its revenue guidance for the second quarter of 2023 to a range of $106 to $108 million and plans to update its annual guidance when it reports its second quarter 2023 financial results.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

opinion
This Canadian aerospace stock deserves a place on your watch list
Robert Tattersall